Showing 41 - 60 results of 132 for search '"ESC Heart Failure"', query time: 0.04s Refine Results
  1. 41
    Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction

    Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction by Shunsuke Tamaki, Takahisa Yamada, Takashi Morita, Yoshio Furukawa, Masato Kawasaki, Atsushi Kikuchi, Tsutomu Kawai, Masahiro Seo, Makoto Abe, Jun Nakamura, Kyoko Yamamoto, Kiyomi Kayama, Masatsugu Kawahira, Kazuya Tanabe, Kunpei Ueda, Takanari Kimura, Daisuke Sakamoto, Yuto Tamura, Takeshi Fujita, Masatake Fukunami

    Published 2020-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 42
    Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure

    Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure by David Carballo, Jérôme Stirnemann, Nicolas Garin, Chistophe Marti, Jacques Serratrice, Sebastian Carballo

    Published 2020-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 43
    Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis

    Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis by Fumi Oike, Hiroki Usuku, Eiichiro Yamamoto, Kyohei Marume, Seiji Takashio, Masanobu Ishii, Noriaki Tabata, Koichiro Fujisue, Kenshi Yamanaga, Daisuke Sueta, Shinsuke Hanatani, Yuichiro Arima, Satoshi Araki, Seitaro Oda, Hiroaki Kawano, Hirofumi Soejima, Kenichi Matsushita, Mitsuharu Ueda, Toshihiro Fukui, Kenichi Tsujita

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 44
    Healthcare resource use of patients with transthyretin amyloid cardiomyopathy

    Healthcare resource use of patients with transthyretin amyloid cardiomyopathy by Rosa Lauppe, Johan Liseth Hansen, Anna Fornwall, Katarina Johansson, Mark H. Rozenbaum, Anne Mette Strand, Merja Vakevainen, Johanna Kuusisto, Einar Gude, J. Gustav Smith, Finn Gustafsson

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 45
    Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index

    Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index by Paolo Tolomeo, Ottavio Zucchetti, Emanuele D'Aniello, Noemi Punzo, Federico Marchini, Luca Di Ienno, Elisabetta Tonet, Rita Pavasini, Claudio Rapezzi, Gianluca Campo, Matteo Serenelli

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 46
    A comparison of drug‐eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure

    A comparison of drug‐eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure by Kun Wang, Le Wang, Hongliang Cong, Jingxia Zhang, Yuecheng Hu, Yingyi Zhang, Rui Zhang, Wenyu Li, Wei Qi

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 47
    Blood pressure categorization and subclinical left ventricular dysfunction in antihypertensive medication‐naive subjects

    Blood pressure categorization and subclinical left ventricular dysfunction in antihypertensive medication‐naive subjects by Koki Nakanishi, Masao Daimon, Yuriko Yoshida, Jumpei Ishiwata, Naoko Sawada, Megumi Hirokawa, Hidehiro Kaneko, Tomoko Nakao, Yoshiko Mizuno, Hiroyuki Morita, Marco R. Di Tullio, Shunichi Homma, Issei Komuro

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 48
    The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles

    The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles by Michiel T.H.M. Henkens, Anne‐Mar vanOmmen, Sharon Remmelzwaal, Gideon B. Valstar, Ping Wang, Job A.J. Verdonschot, Mark R. Hazebroek, Leonard Hofstra, Vanessa P.M. vanEmpel, Joline W.J. Beulens, Hester M. denRuijter, Stephane R.B. Heymans

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 49
    Characterization of heart failure patients with reverse left ventricular remodelling post‐angiotensin receptor blockers/neprilysin inhibitors therapy

    Characterization of heart failure patients with reverse left ventricular remodelling post‐angiotensin receptor blockers/neprilysin inhibitors therapy by Leonid Maizels, Yishay Wasserstrum, Boris Fishman, Amitai Segev, David Ben‐Nun, Anan Younis, Dov Freimark, Israel Mazin, Avishay Grupper

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 50
    Comprehensive symptom assessment using Integrated Palliative care Outcome Scale in hospitalized heart failure patients

    Comprehensive symptom assessment using Integrated Palliative care Outcome Scale in hospitalized heart failure patients by Yasuhiro Hamatani, Moritake Iguchi, Yurika Ikeyama, Atsuko Kunugida, Megumi Ogawa, Natsushige Yasuda, Kana Fujimoto, Hidenori Ichihara, Misaki Sakai, Tae Kinoshita, Yasuyo Nakashima, Masaharu Akao

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 51
    Cardiologists' attitudes on communication about prognosis with heart failure patients

    Cardiologists' attitudes on communication about prognosis with heart failure patients by Martje H.L. van derWal, Lisa Hjelmfors, Anna Strömberg, Tiny Jaarsma

    Published 2020-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 52
    Rationale and design of the CardioMEMS Post‐Market Multinational Clinical Study: COAST

    Rationale and design of the CardioMEMS Post‐Market Multinational Clinical Study: COAST by Martin R. Cowie, Pascal deGroote, Scott McKenzie, Marie‐Elena Brett, Philip B. Adamson, the CardioMEMS Post‐Market Study Investigators

    Published 2020-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 53
    Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting

    Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting by Charlotte Nordberg Backelin, Michael Fu, Charlotta Ljungman

    Published 2020-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 54
    A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan

    A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan by Naoya Nakashima, Seiji Takashio, Mami Morioka, Masato Nishi, Toshihiro Yamada, Kyoko Hirakawa, Masanobu Ishii, Noriaki Tabata, Kenshi Yamanaga, Koichiro Fujisue, Daisuke Sueta, Hisanori Kanazawa, Tadashi Hoshiyama, Shinsuke Hanatani, Satoshi Araki, Hiroki Usuku, Eiichiro Yamamoto, Mitsuharu Ueda, Kenichi Matsushita, Kenichi Tsujita

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 55
    Hypochloraemia and 30 day readmission rate in patients with acute decompensated heart failure

    Hypochloraemia and 30 day readmission rate in patients with acute decompensated heart failure by Roman Marchenko, Adam Sigal, Thomas E. Wasser, Jessica Reyer, Jared Green, Christopher Mercogliano, Muhammad Sohail Khan, Anthony A. Donato

    Published 2020-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 56
    Variation in clinical and patient‐reported outcomes among complex heart failure with preserved ejection fraction phenotypes

    Variation in clinical and patient‐reported outcomes among complex heart failure with preserved ejection fraction phenotypes by Kelsey M. Flint, Sanjiv J. Shah, Eldrin F. Lewis, David P. Kao

    Published 2020-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 57
    Non‐invasive telemedical care in heart failure patients and stroke: post hoc analysis of TIM‐HF and TIM‐HF2 trials

    Non‐invasive telemedical care in heart failure patients and stroke: post hoc analysis of TIM‐HF and TIM‐HF2 trials by Serdar Tütüncü, Marcus Honold, Kerstin Koehler, Oliver Deckwart, Friedrich Koehler, Karl Georg Haeusler

    Published 2020-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 58
    Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease

    Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease by Entela Bollano, Björn Redfors, Araz Rawshani, Dimitrios Venetsanos, Sebastian Völz, Oskar Angerås, Charlotta Ljungman, Joakim Alfredsson, Tomas Jernberg, Truls Råmunddal, Petur Petursson, J. Gustav Smith, Oscar Braun, Henrik Hagström, Ole Fröbert, David Erlinge, Elmir Omerovic

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 59
    Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure

    Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure by Akihiro Shirakabe, Hirotake Okazaki, Masato Matsushita, Yusaku Shibata, Shota Shigihara, Suguru Nishigoori, Tomofumi Sawatani, Nozomi Sasamoto, Kazutaka Kiuchi, Masanori Atsukawa, Norio Itokawa, Taeang Arai, Nobuaki Kobayashi, Kuniya Asai

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 60
    Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence

    Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence by Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

    Published 2022-06-01
    “…ESC Heart Failure…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: